Antifungal activity of lactobacillus against microsporum canis, microsporum gypseum and epidermophyton floccosum

Bioengineered Bugs

Volumn 3, Issue 2, 2012, Pages 104-113

  Guo, Jiahui ^a   Brosnan, Brid ^a   Furey, Ambrose ^a   Arendt, Elke K ^b   Murphy, Padraigin ^a   Coffey, Aidan ^a  

^a Munster Technological University   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Antifungal; Epidermophyton floccosum; Lactic acid bacteria; Microsporum canis; Microsporum gypseum

Indexed keywords

AGAR;

ACCURACY; ANTIFUNGAL ACTIVITY; ARTHRODERMA GYPSEUM; ARTICLE; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; BACTERIAL STRAIN; BACTERIUM ISOLATE; CELL FREE SYSTEM; DERMATOPHYTE; EPIDERMOPHYTON FLOCCOSUM; FREEZE DRYING; FUNGAL COMMUNITY; FUNGUS GROWTH; INHIBITION KINETICS; LACTIC ACID BACTERIUM; LACTOBACILLUS; LACTOBACILLUS REUTERI; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MICROSPORUM CANIS; NONHUMAN; PH;

ARTHRODERMA GYPSEUM; ARTHRODERMATACEAE; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; EPIDERMOPHYTON FLOCCOSUM; FUNGI; LACTOBACILLUS; MICROSPORUM CANIS;

EID: 84861776211     PISSN: 19491018     EISSN: 19491026     Source Type: Journal    
DOI: 10.4161/bbug.19624     Document Type: Article

References (54)

1. Seebacher C, Bouchara JP, Mignon B. Updates on the epidemiology of dermatophyte infections. Mycopathologia 2008; 166:335-352; PMID:18478365; http://dx.doi.org/10.1007/s11046-008-9100-9
2. Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses 2008; 51(Suppl 4):2-15; PMID:18783559; http://dx.doi.org/10.1111/j.1439-0507.2008.01606.x
3. Méndez-Tovar LJ, Manzano-Gayosso P, Velásquez-Hernández V, Millan-Chiu B, Hernández-Hernández F, Mondragón-González R, et al. [Resistance to azolic compounds in clinical Trichophyton spp. strains]. Rev Iberoam Micol 2007; 24:320-322; PMID:18095769
4. Manzano-Gayosso P, Méndez-Tovar LJ, Hernández-Hernández F, López-Martínez R. [Antifungal resistance: an emerging problem in Mexico]. Gac Med Mex 2008; 144:23-26; PMID:18619054
5. Coelho LM, Aquino-Ferreira R, Maffei CM, Martinez-Rossi NM. In vitro antifungal drug susceptibilities of dermatophytes microconidia and arthroconidia. J Antimicrob Chemother 2008; 62:758-761; PMID:18552341; http://dx.doi.org/10.1093/jac/dkn245
6. Martinez-Rossi NM, Peres NT, Rossi A. Antifungal resistance mechanisms in dermatophytes. Mycopathologia 2008; 166:369-383; PMID:18478356; http://dx.doi.org/10.1007/s11046-008-9110-7
7. Peres NT, Maranhão FC, Rossi A, Martinez-Rossi NM. Dermatophytes: host-pathogen interaction and antifungal resistance. An Bras Dermatol 2010; 85:657-667; PMID:21152790; http://dx.doi.org/10.1590/S0365-05962010000500009
8. Chen J, Song X, Yang P, Wang J. Appearance of anaphylactic shock after long-term intravenous itraconazole treatment. Ann Pharmacother 2009; 43:537-541; PMID:19261964; http://dx.doi.org/10.1345/aph.1L343
9. Tapaninen T, Backman JT, Kurkinen KJ, Neuvonen PJ, Niemi M. Itraconazole, a P-glycoprotein and CYP3A4 inhibitor, markedly raises the plasma concentrations and enhances the renin-inhibiting effect of aliskiren. J Clin Pharmacol 2011; 51:359-367; PMID:20400651; http://dx.doi.org/10.1177/0091270010365885
10. Back DJ, Tjia JF. Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes. Br J Clin Pharmacol 1991; 32:624-626; PMID:1659439
11. Venkatakrishnan K, von Moltke LL, Greenblatt DJ. Effects of the antifungal agents on oxidative drug metabolism: clinical relevance. Clin Pharmacokinet 2000; 38:111-180; PMID:10709776; http://dx.doi.org/10.2165/00003088-200038020-00002
12. Ohno T, Nakayama K, Nakade S, Kitagawa J, Ueda S, Miyabe H, et al. Effect of itraconazole on the pharmacokinetics of imidafenacin in healthy subjects. J Clin Pharmacol 2008; 48:330-334; PMID:18218784; http://dx.doi.org/10.1177/0091270007310386
13. Klepser M. The value of amphotericin B in the treatment of invasive fungal infections. J Crit Care 2011; 26:225, e1-e10; PMID:20951541
14. Laniado-Laborín R, Cabrales-Vargas MN. Amphotericin B: side effects and toxicity. Rev Iberoam Micol 2009; 26:223-227; PMID:19836985; http://dx.doi.org/10.1016/j.riam.2009.06.003
15. Baginski M, Czub J. Amphotericin B and its new derivatives-mode of action. Curr Drug Metab 2009; 10:459-469; PMID:19689243; http://dx.doi.org/10.2174/138920009788898019
16. Flach A, Gregel B, Simionatto E, da Silva UF, Zanatta N, Morel AF, et al. Chemical analysis and antifungal activity of the essential oil of Calea clematidea. Planta Med 2002; 68:836-838; PMID:12357399; http://dx.doi.org/10.1055/s-2002-34414
17. Mimica-Dukić N, Bozin B, Soković M, Mihajlović B, Matavulj M. Antimicrobial and antioxidant activities of three Mentha species essential oils. Planta Med 2003; 69:413-419; PMID:12802721; http://dx.doi.org/10.1055/s-2003-39704
18. Rapp RP. Changing strategies for the management of invasive fungal infections. Pharmacotherapy 2004; 24:4S-28S, quiz 29S-32S; PMID:14992487; http://dx.doi.org/10.1592/phco.24.3.4S.33151
19. Bajpai VK, Yoon JI, Kang SC. Antifungal potential of essential oil and various organic extracts of Nandina domestica Thunb. against skin infectious fungal pathogens. Ppl Microbiol Biotechnol 2009; 83:1127-1133; PMID:19415265; http://dx.doi.org/10.1007/s00253-009-2017-5
20. Cotter PD, Hill C, Ross RP. Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 2005; 3:777-788; PMID:16205711; http://dx.doi.org/10.1038/nrmicro1273
21. De Vuyst L, Leroy F. Bacteriocins from lactic acid bacteria: production, purification, and food applications. J Mol Microbiol Biotechnol 2007; 13:194-199; PMID:17827969; http://dx.doi.org/10.1159/000104752
22. Sit CS, Vederas JC. Approaches to the discovery of new antibacterial agents based on bacteriocins. Biochem Cell Biol 2008; 86:116-123; PMID:18443625; http://dx.doi.org/10.1139/O07-153
23. Piper C, Cotter PD, Ross RP, Hill C. Discovery of medically significant lantibiotics. Curr Drug Discov Technol 2009; 6:1-18; PMID:19275538; http://dx.doi.org/10.2174/157016309787581075
24. Magnusson J, Ström K, Roos S, Sjögren J, Schnürer J. Broad and complex antifungal activity among environmental isolates of lactic acid bacteria. FEMS Microbiol ett 2003; 219:129-135; PMID:12594034; http://dx.doi.org/10.1016/S0378-1097(02)01207-7
25. Ström K, Schnürer J, Melin P. Co-cultivation of antifungal Lactobacillus plantarum MiLAB 393 and Aspergillus nidulans, evaluation of effects on fungal growth and protein expression. FEMS Microbiol Lett 2005; 246:119-124; PMID:15869970; http://dx.doi.org/10.1016/j.femsle.2005.03.047
26. Hassan YI, Bullerman LB. Antifungal activity of Lactobacillus paracasei ssp. tolerans isolated from a sourdough bread culture. Int J Food Microbiol 2008; 21:112-115; PMID:18077044; http://dx.doi.org/10.1016/j.ijfoodmicro.2007.11.038
27. Mauch A, Dal Bello F, Coffey A, Arendt EK. The use of Lactobacillus brevis PS1 to in vitro inhibit the outgrowth of Fusarium culmorum and other common usarium species found on barley. Int J Food Microbiol 2010; 141:116-121; PMID:20580986; http://dx.doi.org/10.1016/j.ijfoodmicro.2010.05.002
28. Lavermicocca P, Valerio F, Visconti A. Antifungal activity of phenyllactic acid against molds isolated from bakery products. Appl Environ Microbiol 2003; 69:634-640; PMID:12514051; http://dx.doi.org/10.1128/AEM.69.1.634-640.2003
29. Schnürer J, Magnusson J. Antifungal lactic acid bacteria as biopreservatives. Trends Food Sci Technol 2005; 16:70-78; http://dx.doi.org/10.1016/j.tifs.2004.02.014
30. Dal Bello F, Clarke CI, Ryan LAM, Ulmer H, Schober TJ, Strom K, et al. Improvement of the quality and shelf life of wheat bread by fermentation with the antifungal strain Lactobacillus plantarum FST 1.7. J Cereal Sci 2007; 45:309-318; http://dx.doi.org/10.1016/j.jcs.2006.09.004
31. Lind H, Sjögren J, Gohil S, Kenne L, Schnürer J, Broberg A. Antifungal compounds from cultures of dairy propionibacteria type strains. FEMS Microbiol ett 2007; 271:310-315; PMID:17456184; http://dx.doi.org/10.1111/j.1574-6968.2007.00730.x
32. Ryan LAM, Dal Bello F, Arendt EK. The use of ourdough fermented by antifungal LAB to reduce the amount of calcium propionate in bread. Int J Food icrobiol 2008; 125:274-278; PMID:18541323; http://dx.doi.org/10.1016/j.ijfoodmicro.2008.04.013
33. Nirenberg H. Untersuchungen über die morphologische Differenzierung in der Fusarium- SektionLiseola. Mitt. Biol Bundesanst. Land-Forstwirtsch. 1976; 169:1-117.
34. Cannon RD, Lamping E, Holmes AR, Niimi K, Baret PV, Keniya MV, et al. Efflux-mediated antifungal drug resistance. Clin Microbiol Rev 2009; 22:291-321; PMID:19366916; http://dx.doi.org/10.1128/CMR.00051-08
35. Gupta AK, Cooper EA. Update in antifungal therapy of dermatophytosis. Mycopathologia 2008; 166:353-367; PMID:18478357; http://dx.doi.org/10.1007/s11046-008-9109-0
36. Kuwaki S, Ohhira I, Takahata M, Murata Y, Tada M. Antifungal activity of the fermentation product of herbs by lactic acid bacteria against tinea. J Biosci Bioeng 2002; 94:401-405; PMID:16233325
37. Martirosyan AO, Mndzhoyan SL, Charyan LM, Akopyan LG, Nikishchenko MN. Antimicrobial activity of lactic acid bacteria from sour milk products Narine, Karine, and Matsun. Appl Biochem Microbiol 2004; 40:178-180; http://dx.doi.org/10.1023/B:ABIM.0000018922.03283.b9
38. Talarico TL, Casas IA, Chung TC, Dobrogosz WJ. Production and isolation of reuterin, a growth inhibitor produced by Lactobacillus reuteri. Antimicrob Agents Chemother 1988; 32:1854-1858; PMID:3245697
39. Cadieux P, Wind A, Sommer P, Schaefer L, Crowley K, Britton RA, et al. Evaluation of reuterin production in urogenital probiotic Lactobacillus reuteri RC-14. Appl Environ Microbiol 2008; 74:4645-4649; PMID:18539802; http://dx.doi.org/10.1128/AEM.00139-08
40. Rouse S, Harnett D, Vaughan A, van Sinderen D. Lactic acid bacteria with potential to eliminate fungal spoilage in foods. J Appl Microbiol 2008; 104:915-923; PMID:17976175; http://dx.doi.org/10.1111/j.1365-2672.2007.03619.x
41. Sjögren J, Magnusson J, Broberg A, Schnürer J, Kenne L. Antifungal 3-hydroxy fatty acids from Lactobacillus plantarum MiLAB 14. Appl Environ Microbiol 2003; 69:7554-7557; PMID:14660414; http://dx.doi.org/10.1128/AEM.69.12.7554-7557.2003
42. Mandal V, Sen SK, Mandal NC. Detection, isolation and partial characterization of antifungal compound(s) produced by Pediococcus acidilactici LAB 5. Nat Prod Commun. 2007; 2:671-674.
43. Broberg A, Jacobsson K, Ström K, Schnürer J. Metabolite profiles of lactic acid bacteria in grass silage. Appl Environ Microbiol 2007; 73:5547-5552; PMID:17616609; http://dx.doi.org/10.1128/AEM.02939-06
44. Ryan LA, Zannini E, Dal Bello F, Pawlowska A, Koehler P, Arendt EK. Lactobacillus amylovorus DSM 19280 as a novel food-grade antifungal agent for bakery products. Int J Food Microbiol 2011; 146:276-283; PMID:21429613; http://dx.doi.org/10.1016/j.ijfoodmicro.2011.02.036
45. Sjögren J, Magnusson J, Broberg A, Schnürer J, Kenne L. Antifungal 3-hydroxy fatty acids from Lactobacillus plantarum MiLAB 14. Appl Environ Microbiol 2003; 69:7554-7557; PMID:14660414; http://dx.doi.org/10.1128/AEM.69.12.7554-7557.2003
46. Aguilar-Guadarrama B, Navarro V, León-Rivera I, Rios MY. Active compounds against tinea pedis dermatophytes from Ageratina pichinchensis var. bustamenta. Nat Prod Res 2009; 23:1559-1565; PMID:19844829; http://dx.doi.org/10.1080/14786410902843301
47. Park MJ, Gwak KS, Yang I, Choi WS, Jo HJ, Chang JW, et al. Antifungal activities of the essential oils in Syzygium aromaticum (L.) Merr. Et Perry and Leptospermum petersonii Bailey and their constituents against various dermatophytes. J Microbiol 2007; 45:460-465; PMID:17978807
48. Pinto E, Vale-Silva L, Cavaleiro C, Salgueiro L. Antifungal activity of the clove essential oil from Syzygium aromaticum on Candida, Aspergillus and dermatophyte species. J Med Microbiol 2009; 58:1454-1462; PMID:19589904; http://dx.doi.org/10.1099/jmm.0.010538-0
49. Guo J, Mauch A, Galle S, Murphy P, Arendt EK, Coffey A. Inhibition of growth of Trichophyton tonsurans by Lactobacillus reuteri. J Appl Microbiol 2011; 111:474-483; PMID:21645181; http://dx.doi.org/10.1111/j.1365-2672.2011.05032.x
50. Meroth CB, Walter J, Hertel C, Brandt MJ, Hammes WP. Monitoring the bacterial population dynamics in sourdough fermentation processes by using PCRdenaturing gradient gel electrophoresis. Appl Environ Microbiol 2003; 69:475-482; PMID:12514030; http://dx.doi.org/10.1128/AEM.69.1.475-482.2003
51. Cohen RI, Altshuller AP. A new spectrophotometric method for the determination of acrolein in combustion gases and in the atmosphere. Anal Chem 1961; 33:726-733; http://dx.doi.org/10.1021/ac60174a020
52. Bauer R, du Toit M, Kossmann J. Influence of environmental parameters on production of the acrolein precursor 3-hydroxypropionaldehyde by Lactobacillus reuteri DSMZ 20016 and its accumulation by wine lactobacilli. Int J Food Microbiol 2010; 137:28-31; PMID:19897270; http://dx.doi.org/10.1016/j.ijfoodmicro.2009.10.012
53. Brosnan B, Coffey A, Arendt E, Furey A. Rapid Identification of Anti-Fungal Compounds Produced by Lactic Acid Bacteria using the LTQ-Orbitrap XL Hybrid Mass Spectrometer. Anal Bioanal Chem 2011; In press.
54. Ström K, Sjögren J, Broberg A, Schnürer J. Lactobacillus plantarum MiLAB 393 produces the antifungal cyclic dipeptides cyclo(L-Phe-L-Pro) and cyclo(L-Phetrans- 4-OH-L-Pro) and 3-phenyllactic acid. Appl Environ Microbiol 2002; 68:4322-4327; PMID:12200282; http://dx.doi.org/10.1128/AEM.68.9.4322-4327.2002